This makes the targetingof the MDM2–p53 axis in these types of cancers especially favorable.13 Glioblastoma is a highly aggressive cancer thatoriginates in astrocytes and is associated with an average survivalrate of 12–15 months. The gene discussed is TP53; the disease is glioblastoma.